BioLineRX Ltd ADR (BLRX)
NCM · ADR · CUSIP 09071M205
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for BLRX and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
09071M205 (prev. 09071M106 )
Market Cap
Micro Cap
ADR Ratio
1:15
Business: BioLineRx LTD., is a publicly-traded, clinical-stage biopharmaceutical company based in Jerusalem, Israel, dedicated to identifying, in-licensing and developing promising therapeutic candidates. The Company in-licenses novel compounds primarily from academic institutions and biotech companies based in Israel, develops them through pre-clinical and/or clinical stages, and then partners with pharmaceutical companies for advanced clinical development and/or commercialization.

Company Contact

CEO
Philip Serlin
CFO
Mali Zeevi
Investor Relations
John Lacey · IR@BioLineRx.com
General Email
info@BioLineRx.com
SEC EDGAR Filings
View filings »